Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of these men will die of causes other than prostate cancer. This is revealed in a ...
People with localized prostate cancer treated according to guidelines developed by an international panel of doctors are more likely to die of something other than the disease, new research shows. A ...
Patients who receive guideline-concordant treatment for nonmetastatic prostate cancer are more likely to die from other causes. Men with nonmetastatic prostate cancer (PCa) who receive treatment ...
What are the current prostate cancer screening guidelines and treatment recommendations? Men may be offered prostate cancer screening at different life stages depending on their individual risk. Age, ...
MedPage Today on MSN
Paradigm Shift for Evaluating, Treating Biochemical Recurrence in Prostate Cancer
When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...
Patients with nonmetastatic prostate cancer are more likely to die from other causes than from cancer when treated per guidelines. The 15-year cancer mortality risk is 5.5% for low-risk and 22% for ...
Risk of death and cause of death 30 years after diagnosis as a proportion of 100 men. Grey figures indicate the proportion of men alive after 30 years, blue figures the proportion of men who died of ...
Novartis today announced multiple US real-world studies delivering new insights across metastatic prostate cancer care. The analyses utilize data from Novartis’ PRECISION platform to evaluate ...
The answer depends on your individual risk for bone fracture and the type of exercise. For most men with early prostate cancer, it’s safe to engage in light or moderate exercise. Physical activity is ...
Thousands of lives are lost every year due to “outdated” NHS guidelines that prevent more men from having a prostate cancer blood test, a leading charity has said. Prostate Cancer UK has called for an ...
To earn CME related to this news article, click here. February 25, 2009 — A new joint guideline produced by the American Society of Clinical Oncology (ASCO) and the American Urological Association ...
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results